Chemoinformaics analysis of 2-BETA-D-GLUCOPYRANOSYLOXY-1,4-BENZOXAZIN-3-ONE
| Molecular Weight | 327.289 | nRot | 3 |
| Heavy Atom Molecular Weight | 310.153 | nRig | 18 |
| Exact Molecular Weight | 327.095 | nRing | 3 |
| Solubility: LogS | -2.231 | nHRing | 2 |
| Solubility: LogP | -0.644 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 42.2315 |
| nHD | 5 | BPOL | 23.7005 |
| QED | 0.437 |
| Synth | 3.963 |
| Natural Product Likeliness | 1.541 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.337 |
| HIA | 0.729 |
| CACO-2 | -5.728 |
| MDCK | 0.000144052 |
| BBB | 0.471 |
| PPB | 0.191313 |
| VDSS | 0.435 |
| FU | 0.716831 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.405 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.559 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.188 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.033 |
| CL | 1.467 |
| T12 | 0.631 |
| hERG | 0.009 |
| Ames | 0.618 |
| ROA | 0.125 |
| SkinSen | 0.402 |
| Carcinogencity | 0.737 |
| EI | 0.009 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.517032 |